0 false false false false false false false false false false true false false false false false false No description of principal activity 2023-06-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP SC625130 2023-06-01 2024-05-31 SC625130 2024-05-31 SC625130 2023-05-31 SC625130 2022-06-01 2023-05-31 SC625130 2023-05-31 SC625130 2022-05-31 SC625130 bus:Director1 2023-06-01 2024-05-31 SC625130 core:WithinOneYear 2024-05-31 SC625130 core:WithinOneYear 2023-05-31 SC625130 core:ShareCapital 2024-05-31 SC625130 core:ShareCapital 2023-05-31 SC625130 bus:SmallEntities 2023-06-01 2024-05-31 SC625130 bus:AuditExemptWithAccountantsReport 2023-06-01 2024-05-31 SC625130 bus:SmallCompaniesRegimeForAccounts 2023-06-01 2024-05-31 SC625130 bus:PrivateLimitedCompanyLtd 2023-06-01 2024-05-31 SC625130 bus:FullAccounts 2023-06-01 2024-05-31
COMPANY REGISTRATION NUMBER: SC625130
Neurotherapy Services Limited
Filleted Unaudited Financial Statements
For the year ended
31 May 2024
Neurotherapy Services Limited
Statement of Financial Position
31 May 2024
2024
2023
Note
£
£
Current assets
Debtors
4
100
100
Cash at bank and in hand
223,166
65,591
---------
--------
223,266
65,691
Creditors: amounts falling due within one year
5
223,166
65,591
---------
--------
Net current assets
100
100
----
----
Total assets less current liabilities
100
100
----
----
Capital and reserves
Called up share capital
100
100
----
----
Shareholder funds
100
100
----
----
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 May 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 21 November 2024 , and are signed on behalf of the board by:
Mrs M S McGowan
Director
Company registration number: SC625130
Neurotherapy Services Limited
Notes to the Financial Statements
Year ended 31 May 2024
1. General information
The company is a private company limited by shares, registered in Scotland. The address of the registered office is 33 Kittoch Street, East Kilbride, G74 4JW.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
4. Debtors
2024
2023
£
£
Amounts owed by group undertakings and undertakings in which the company has a participating interest
100
100
----
----
5. Creditors: amounts falling due within one year
2024
2023
£
£
Other creditors
223,166
65,591
---------
--------
6. Related party transactions
Control: The company was under the control of the director throughout the period under review. Transactions: No transactions with related parties were undertaken such as are required to be disclosed under Section 1A of FRS 102.
7. Controlling party
The ultimate parent undertaking of the company is Mar House Limited , a company registered in Scotland, which owns the entire issued share capital of the company.